Literature DB >> 597272

The inhibition of lipid autoxidation by human caeruloplasmin.

D J Al-Timimi, T L Dormandy.   

Abstract

1. Purified caeruloplasmin was shown to inhibit lipid autoxidation induced by ascorbic acid or inorganic iron in the following systems: (a) an emulsion of linolenic acid in water; (b) an untreated ox brain homogenate in phosphate buffer; (c) a similar homogenate whose susceptibility to autoxidation had been abolished by dialysis or by heating and then restored by the above pro-oxidants. 2. The optimum conditions for this antioxidant activity were studied. 3. Caeruloplasmin did not inhibit autoxidation by u.v. irradiation in dialysed or preheated homogenates. 4. The apoprotein (without copper) had no antioxidant activity, whereas CuSO4 alone was much less effective as an antioxidant. 5. Iron-free transferrin also had some antioxidant activity.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 597272      PMCID: PMC1183762          DOI: 10.1042/bj1680283

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  15 in total

1.  Inhibition of lipid peroxide formation by vertebrate blood serum.

Authors:  A A BARBER
Journal:  Arch Biochem Biophys       Date:  1961-01       Impact factor: 4.013

2.  ADP-ACTIVATED LIPID PEROXIDATION COUPLED TO THE TPNH OXIDASE SYSTEM OF MICROSOMES.

Authors:  P HOCHSTEIN; L ERNSTER
Journal:  Biochem Biophys Res Commun       Date:  1963-08-14       Impact factor: 3.575

3.  MECHANISMS OF LIPID PEROXIDE FORMATION IN TISSUES. ROLE OF METALS AND HAEMATIN PROTEINS IN THE CATALYSIS OF THE OXIDATION UNSATURATED FATTY ACIDS.

Authors:  E D WILLS
Journal:  Biochim Biophys Acta       Date:  1965-04-05

4.  Rapid method for preparation of crystalline human ceruloplasmin from Cohn fraction IV-1.

Authors:  H F DEUTSCH; C B KASPER; D A WALSH
Journal:  Arch Biochem Biophys       Date:  1962-10       Impact factor: 4.013

5.  The heterogeneity of the copper-containing protein of human plasma, ceruloplasmin.

Authors:  S Z HIRSCHMAN; A G MORELL; I H SCHEINBERG
Journal:  Ann N Y Acad Sci       Date:  1961-11-02       Impact factor: 5.691

6.  Studies of the mechanism of vitamin E action. IV. Lipide peroxidation in the vitamin E-deficient rabbit.

Authors:  H ZALKIN; A L TAPPEL
Journal:  Arch Biochem Biophys       Date:  1960-05       Impact factor: 4.013

7.  Oxidase reactions in human plasma caused by coeruloplasmin.

Authors:  C G HOLMBERG; C B LAURELL
Journal:  Scand J Clin Lab Invest       Date:  1951       Impact factor: 1.713

8.  Lipid peroxide formation in rat brain.

Authors:  S Bishayee; A S Balasubramanian
Journal:  J Neurochem       Date:  1971-06       Impact factor: 5.372

9.  Assay using brain homogenate for measuring the antioxidant activity of biological fluids.

Authors:  J Stocks; J M Gutteridge; R J Sharp; T L Dormandy
Journal:  Clin Sci Mol Med       Date:  1974-09

10.  Biological rancidification.

Authors:  T L Dormandy
Journal:  Lancet       Date:  1969-09-27       Impact factor: 79.321

View more
  20 in total

1.  Erythrocyte antioxidant system and serum ceruloplasmin levels in welders.

Authors:  R Mongiat; G C Gerli; G F Locatelli; R Fortuna; A Petazzi
Journal:  Int Arch Occup Environ Health       Date:  1992       Impact factor: 3.015

2.  Antioxidant macromolecules in the epithelial lining fluid of the normal human lower respiratory tract.

Authors:  A M Cantin; G A Fells; R C Hubbard; R G Crystal
Journal:  J Clin Invest       Date:  1990-09       Impact factor: 14.808

3.  Prognostic value of elevated serum ceruloplasmin levels in patients with heart failure.

Authors:  Muhammad Hammadah; Yiying Fan; Yuping Wu; Stanley L Hazen; W H Wilson Tang
Journal:  J Card Fail       Date:  2014-08-13       Impact factor: 5.712

4.  Role of endogenous ceruloplasmin in low density lipoprotein oxidation by human U937 monocytic cells.

Authors:  E Ehrenwald; P L Fox
Journal:  J Clin Invest       Date:  1996-02-01       Impact factor: 14.808

5.  Serum copper and related variables in rheumatoid arthritis.

Authors:  P R Scudder; D Al-Timimi; W McMurray; A G White; B C Zoob; T L Dormandy
Journal:  Ann Rheum Dis       Date:  1978-02       Impact factor: 19.103

6.  Synovial fluid copper and related variables in rheumatoid and degenerative arthritis.

Authors:  P R Scudder; W McMurray; A G White; T L Dormandy
Journal:  Ann Rheum Dis       Date:  1978-02       Impact factor: 19.103

7.  Intact human ceruloplasmin oxidatively modifies low density lipoprotein.

Authors:  E Ehrenwald; G M Chisolm; P L Fox
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

8.  Lipid peroxidation products and antioxidant proteins in plasma and cerebrospinal fluid from multiple sclerosis patients.

Authors:  M I Hunter; B C Nlemadim; D L Davidson
Journal:  Neurochem Res       Date:  1985-12       Impact factor: 3.996

Review 9.  Copper and inflammation--a possible rationale for the pharmacological manipulation of inflammatory disorders.

Authors:  R Milanino; A Conforti; L Franco; M Marrella; G Velo
Journal:  Agents Actions       Date:  1985-09

10.  Copper and aspirin treatment increase the antioxidant activity of plasma.

Authors:  M C McGahan
Journal:  Agents Actions       Date:  1990-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.